ArticleInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2021

Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.

Rebecca Kristeleit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.